NxtCure Labs入选YC Fall 2026
摘要
创始人是III期癌症幸存者，曾借早期版本找到临床试验。公司为肿瘤药物研发构建数字孪生，模拟数千名虚拟患者预估给药方案，AI代理承担选中心、预筛患者等试验工作，关键决策由医生把关。
原文片段
NxtCure Labs - The full-stack AI CRO Oncology Engineering cancer drugs, faster. Alessandro Hammond is a Stage III cancer survivor. On January 15, 2026, Alessandro went in for an innocuous lump, which turned out to be an aggressive tumor. Alessandro was rushed into emergency surgery. He used an earl…